腎髓質(zhì)PGE2及腎素受體在糖尿病腎病和高血壓中的作用_第1頁(yè)
腎髓質(zhì)PGE2及腎素受體在糖尿病腎病和高血壓中的作用_第2頁(yè)
腎髓質(zhì)PGE2及腎素受體在糖尿病腎病和高血壓中的作用_第3頁(yè)
腎髓質(zhì)PGE2及腎素受體在糖尿病腎病和高血壓中的作用_第4頁(yè)
腎髓質(zhì)PGE2及腎素受體在糖尿病腎病和高血壓中的作用_第5頁(yè)
已閱讀5頁(yè),還剩35頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

InteractionbetweenRenalMedullaryPGE2and(P)RRinDiabeticNephropathyandHypertensionTianxinYang1,2andWeidongWang11InstituteofHypertension,SunYat-senUniversitySchoolofMedicine;2DepartmentofInternalMedicine,UniversityofUtahPrevalenceofCKDCDC2010IncidentRateofESRDNIDDK2010ESRDCostsNIDDK2010DiabetesHypertensionGlomerulonephritisPKDKidneystonesDrugsRASProteinuriaPodocytedamageDiabetesMellitusandDiabeticNephropathyNearly26millionAmericanshavediabetes,accordingtonewestimatesfromtheCentersforDiseaseControlandPrevention(CDC).Inaddition,anestimated79millionU.S.adultshaveprediabetes,aconditioninwhichbloodsugarlevelsarehigherthannormal,butnothighenoughtobediagnosedasdiabetes.Prediabetesraisesaperson'sriskoftype2diabetes,heartdiseaseandstroke.Diabetesaffects8.3percentofAmericansofallages,and11.3percentofadultsaged20andolder,accordingtotheNationalDiabetesFactSheetfor2011.About27percentofthosewithdiabetes—7millionAmericans—donotknowtheyhavethedisease.Prediabetesaffects35percentofadultsaged20andolder.NationalDiabetesFactSheetfor2011,CDCAnnualNumber(inThousands)ofNewCasesofDiagnosedDiabetesAmongAdultsAged18–79Years,UnitedStates,1980–2010From1980through2010,thenumberofadultsintheUnitedStatesaged18–79withnewlydiagnoseddiabetesmorethantripledfrom493,000in1980toover1.7millionin2010.Thenumberofnewcasesofdiabeteshasincreasedsincetheearly1990s.From2008through2010,thenumberofnewcasesofdiagnoseddiabeteshasshownlittlechange.NationalDiabetesFactSheetfor2011,CDCNumber(inMillions)ofCivilian,NoninstitutionalizedAdultswithDiagnosedDiabetes,UnitedStates,1980–2010From1980through2010,thenumberofU.S.adultsaged18yearsorolderwithdiagnoseddiabeteshasmorethantripled(from5.5millionto20.7million).NationalDiabetesFactSheetfor2011,CDCTheoverallprevalencesoftotaldiabetes(previouslydiagnosedpluspreviouslyundiagnoseddiabetes)andprediabeteswere9.7%and15.5%,respectively.Inthemultivariable,multinomial,logitmodels,malesex,olderage,afamilyhistoryofdiabetes,overweight,obesity,centralobesity,increasedheartrate,elevatedsystolicbloodpressure,elevatedserumtriglyceridelevel,educationallevelbelowcollege,andurbanresidencewereallsignificantlyassociatedwithanincreasedriskofdiabetesandprediabetes.YangetalNEngJMed2010Epidemiology

Diabeticnephropathyisthemostcommoncauseofchronickidneyfailureandend-stagekidneydiseaseintheUnitedStates,accountingfor44%ofallnewcasesofkidneyfailureintheUnitedStatesin2008.Peoplewithbothtype1andtype2diabetesareatrisk.Theriskishigherifblood-glucoselevelsarepoorlycontrolled.Furthermore,oncenephropathydevelops,thegreatestrateofprogressionisseeninpatientswithpoorcontroloftheirbloodpressure.Alsopeoplewithhighcholesterollevelintheirbloodhavemuchmoreriskthanothers.糖尿病腎病在西方國(guó)家是導(dǎo)致慢性腎病和終末期腎病的最主要病因,在我們國(guó)家主要病因仍為原發(fā)性腎小球疾病,但糖尿病腎病的發(fā)病率有逐年增高的趨勢(shì)。以腎小球病變?yōu)樘卣鞯奶悄虿∧I病大約在糖尿病診斷之后15至20年出現(xiàn),病程呈進(jìn)展性大約1/3的糖尿病病人有腎臟受累

糖尿病腎病Diabeticnephropathy,alsoknownasnodulardiabeticglomerulosclerosisandintercapillaryglomerulonephritis,isaprogressivekidneydiseasecausedbyangiopathyofcapillariesinthekidneyglomeruli.Itischaracterizedbynephroticsyndromeanddiffuseglomerulosclerosis.Itisduetolongstandingdiabetesmellitus,andisaprimeindicationfordialysisinmanyWesterncountries.(Pro)reninReceptorandDiabeticNephropathy圖1.腎素-血管緊張素系統(tǒng)與糖尿病腎病的治療策略RAS(Pro)ReninReceptor(PRR):ANewComponentoftheRASBatenburgWW,JanDanserAH.EurJPharmacol.2008May118.Review.SystemicRASSchematicpresentationofthemainstepsintheRAAScascadeandsitesofactionoftheRAASinhibitors(Pro)reninReceptorandHypertensionCollectingDuctReninSystemAngII膜磷脂花生四烯酸ProstanoidSynthesisPathwaymPGES-1AngIIStmulates(P)RRExpressioninPrimaryRatIMCDCellsControlAngIIPRR43kDaβ-Actin43kDaP<0.05AngIIStimulatesCOX-2ExpressioninPrimaryRatIMCDCellsControlAngII(4hr)AngII(12hr)AngII(8hr)43kDaCOX-2P<0.05PRRProteinExpressioninIMCDCellsafter12HoursofAngIITreatmentwithorwithoutNS-398AngIIP<0.05P<0.01PRR43kDaAngII+NS-398VehicleMediumReninActivityP<0.05P<0.05EffectofExogenousPGE2onPRRExpression

PRRVehiclePGE2P<0.0143kDaExogen

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論